The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 08, 2024

Filed:

Aug. 26, 2019
Applicant:

Dana-farber Cancer Institute, Inc., Boston, MA (US);

Inventors:

William C. Hahn, Newton, MA (US);

Joseph Rosenbluh, Brookline, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); A61K 45/06 (2006.01); C07K 14/47 (2006.01); C12N 15/113 (2010.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 45/06 (2013.01); C07K 14/47 (2013.01); C07K 14/4702 (2013.01); C07K 14/4747 (2013.01); C12N 15/1135 (2013.01); G01N 33/5017 (2013.01); C12N 2310/14 (2013.01); C12N 2310/3233 (2013.01); C12N 2310/531 (2013.01); G01N 2500/10 (2013.01);
Abstract

The present invention provides methods of treating a subject having a Wnt/beta-catenin active cancer by administering to said subject a compound that inhibits the expression or activity of YES1, BIRC5 or BCL2L1, a compound that inhibits YAP1-beta-catenin complex formation, a compound that inhibits YAP1-beta-catenin complex binding to DNA, a compound that inhibits YAP1-beta-catenin-TBX5 complex formation, or any combination thereof. The compound can be, for example, a nucleic acid, a peptide, an antibody or a small molecule. Methods of screening for therapeutic targets for treating cancer are included.


Find Patent Forward Citations

Loading…